News Posts List
Comparison of Outcomes After Minimally Invasive Versus Open Partial Nephrectomy
01/24/2014
Complication rates of open partial nephrectomies (OPN) and minimally invasive partial nephrectomies (MIPN) have largely been reported by single and multi-institutional tertiary care centers.
One in three kidney cancer patients don't get drugs they need
01/22/2014
One in three patients with kidney cancer eligible to receive one of two new medicines – sunitinib or pazopanib – did not get them due to the area they live in.
A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma
01/22/2014
DNA aptamers represent a novel strategy in anti-cancer medicine.
Marston Linehan, MD: The Genetic Basis of Kidney Cancer (VIDEO)
01/22/2014
VIDEO: NCI's Dr. Marston Linehan on 30 years of research into the genetic basis of kidney cancer.
Yale: Hereditary Kidney Cancer Program
01/22/2014
5-8% of kidney cancers have a genetic predisposition.
The Young and the ObamaCare-less
01/21/2014
This is a failure by President Obama's own standard. About one of six Americans under age 65 lack insurance in the official statistics. So where are they? Either Democrats exaggerated the problem to pass the new entitlement. Or else individuals don't think ObamaCare plans offer value, and they're choosing to stay uninsured or buy insurance off the exchanges where the regulations are slightly looser.
Biomarkers of renal cell carcinoma
01/21/2014
The incidence of renal cell carcinoma (RCC) has increased steadily in past few decades and is partially attributable to the increased utilization of cross-sectional imaging.
Exploiting Glycans for Potential Cancer Vaccines
01/21/2014
Researchers are tackling TACAs in the search for better immunotherapies.
Kidney cancer before age 47 implies hereditary cause
01/19/2014
The diagnosis of renal cell cancer in a patient aged 46 or younger should prompt a referral for germline mutation testing and genetic counseling, according to a report published online in the Journal of Clinical Oncology.